There are only four basic modes of cell death, although there are many ad-hoc variants adapted to different situations

[1]  J. Kers,et al.  An Overview of Pathways of Regulated Necrosis in Acute Kidney Injury. , 2016, Seminars in nephrology.

[2]  G. Giaccone,et al.  Cell Death Independent of Caspases: A Review , 2005, Clinical Cancer Research.

[3]  P. Bonaldo,et al.  Role of macrophages in Wallerian degeneration and axonal regeneration after peripheral nerve injury , 2015, Acta Neuropathologica.

[4]  P. Vandenabeele,et al.  Mouse mammary gland involution is associated with cytochrome c release and caspase activation , 2001, Mechanisms of Development.

[5]  A. Stojadinovic,et al.  Apoptosis in Living Animals Is Assisted by Scavenger Cells and Thus May Not Mainly Go through the Cytochrome C-Caspase Pathway , 2013, Journal of Cancer.

[6]  N. Xu,et al.  Is Type 2 Diabetes One of Such Aging Phenomena That Lack an Irreversible Structural Change , 2015 .

[7]  D. Green,et al.  Programmed necrosis in inflammation: Toward identification of the effector molecules , 2016, Science.

[8]  R. DePinho,et al.  Cancer: Crime and punishment , 2005, Nature.

[9]  A. Costanzo,et al.  Programmed cell death in the skin. , 2015, The International journal of developmental biology.

[10]  B. Brüne,et al.  Apoptotic cells promote macrophage survival by releasing the antiapoptotic mediator sphingosine-1-phosphate. , 2006, Blood.

[11]  B. Brüne,et al.  Apoptotic cells enhance sphingosine‐1‐phosphate receptor 1 dependent macrophage migration , 2013, European journal of immunology.

[12]  R. Lucianò,et al.  Mitotic Catastrophe in Malignant Epithelial Tumors: The Pathologist’s Viewpoint , 2011, Ultrastructural pathology.

[13]  N. Xu.  Does the Cytochrome C-Caspase Pathway of Cell Death Occur Physiologically in Animals? , 2017 .

[14]  Batoul Y. Abdallah,et al.  Heterogeneity of Cell Death , 2013, Cytogenetic and Genome Research.

[15]  Siqi Liu,et al.  The other side of the coin: The tumor-suppressive aspect of oncogenes and the oncogenic aspect of tumor-suppressive genes, such as those along the CCND–CDK4/6–RB axis , 2014, Cell cycle.

[16]  H. Anders,et al.  Matters of life and death. How neutrophils die or survive along NET release and is “NETosis” = necroptosis? , 2016, Cellular and Molecular Life Sciences.

[17]  T. Dawson,et al.  Parthanatos: mitochondrial‐linked mechanisms and therapeutic opportunities , 2014, British journal of pharmacology.

[18]  K. Ravichandran.  Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways. , 2011, Immunity.

[19]  K. Choi,et al.  Paraptosis in the anti-cancer arsenal of natural products. , 2016, Pharmacology & therapeutics.

[20]  P. Henson.  Dampening inflammation , 2005, Nature Immunology.

[21]  D. Green,et al.  Caspase-independent cell death: leaving the set without the final cut , 2008, Oncogene.

[22]  Batoul Y. Abdallah,et al.  Diverse system stresses: common mechanisms of chromosome fragmentation , 2011, Cell Death and Disease.

[23]  E. Epel,et al.  Lifespan adversity and later adulthood telomere length in the nationally representative US Health and Retirement Study , 2016, Proceedings of the National Academy of Sciences.

[24]  D. Liao.  The scavenger cell hypothesis of apoptosis: apoptosis redefined as a process by which a cell in living tissue is destroyed by phagocytosis. , 2005, Medical hypotheses.

[25]  Ningzhi Xu,et al.  Protecting the normal in order to better kill the cancer , 2015, Cancer medicine.

[26]  B. Hanson.  Necroptosis: A new way of dying? , 2016, Cancer biology & therapy.

[27]  J. Turkson,et al.  Stat3 controls lysosomal-mediated cell death in vivo , 2011, Nature Cell Biology.

[28]  H. Heng,et al.  Mitotic cell death by chromosome fragmentation. , 2007, Cancer research.

[29]  E. Gavathiotis,et al.  Chemical genetics: Unraveling cell death mysteries. , 2016, Nature chemical biology.

[30]  S. Dixon,et al.  Mechanisms of ferroptosis , 2016, Cellular and Molecular Life Sciences.

[31]  L. Formigli,et al.  Aponecrosis: Morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis , 2000, Journal of cellular physiology.

[32]  M. Overholtzer,et al.  Entosis: Cell-in-Cell Formation that Kills Through Entotic Cell Death. , 2015, Current molecular medicine.

[33]  J. Gustafsson,et al.  Persistent sex differences in growth control of early rat liver lesions are programmed during promotion in the resistant hepatocyte model , 1996, Hepatology.

[34]  K. Ravichandran,et al.  Metabolic Connections during Apoptotic Cell Engulfment , 2011, Cell.

[35]  H. Merker,et al.  The morphology of various types of cell death in prenatal tissues. , 1973, Teratology.

[36]  R. Dickson,et al.  Cell Death in MMTV-c-myc Transgenic Mouse Mammary Tumors May Not Be Typical Apoptosis , 2003, Laboratory Investigation.

[37]  W. Maltese,et al.  Methuosis: nonapoptotic cell death associated with vacuolization of macropinosome and endosome compartments. , 2014, The American journal of pathology.

[38]  R. Jirtle,et al.  Liver tumor promoter phenobarbital: a biphasic modulator of hepatocyte proliferation. , 1991, Progress in clinical and biological research.

[39]  H. Horvitz,et al.  Both the apoptotic suicide pathway and phagocytosis are required for a programmed cell death in Caenorhabditis elegans , 2016, BMC Biology.

[40]  Gangshi Wang,et al.  Learning about the Importance of Mutation Prevention from Curable Cancers and Benign Tumors , 2016, Journal of Cancer.

[41]  A. Alimonti,et al.  Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer. , 2016, Trends in cell biology.

[42]  S. Nagata,et al.  Autoimmunity and the Clearance of Dead Cells , 2010, Cell.

[43]  M. Lisanti,et al.  c-Myc induction of programmed cell death may contribute to carcinogenesis , 2011, Cancer biology & therapy.

[44]  E. Giannoni,et al.  Anoikis: an emerging hallmark in health and diseases , 2012, The Journal of pathology.

[45]  D. Liao,et al.  c-Myc in breast cancer. , 2000, Endocrine-related cancer.

[46]  P. Clarke,et al.  Nineteenth century research on cell death. , 2012, Experimental oncology.

[47]  K. Uemura,et al.  Regulated necrosis and its implications in toxicology. , 2015, Toxicology.

[48]  S. Fulda,et al.  Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy , 2006, Oncogene.

[49]  M. Overholtzer,et al.  Mechanisms and consequences of entosis , 2016, Cellular and Molecular Life Sciences.

[50]  S. Gould,et al.  Phenobarbitone-induced liver response in wild type and in p53 deficient mice. , 2001, Toxicology letters.

[51]  G. Pawelec,et al.  Lifespans of T lymphocytes , 1996, Mechanisms of Ageing and Development.

[52]  B. Zhivotovsky,et al.  Mitotic catastrophe and cancer drug resistance: A link that must to be broken. , 2016, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[53]  M. Watve,et al.  Evolution of Aging and Death: What Insights Bacteria Can Provide , 2014, The Quarterly Review of Biology.

[54]  Robert A. Gatenby,et al.  Life history trade-offs in cancer evolution , 2013, Nature Reviews Cancer.

[55]  Lawrence Buja,et al.  Oncosis: an important non-apoptotic mode of cell death. , 2012, Experimental and molecular pathology.

[56]  D Andrews,et al.  Essential versus accessory aspects of cell death: recommendations of the NCCD 2015 , 2014, Cell Death and Differentiation.

[57]  R. Knight,et al.  How many ways to die? How many different models of cell death? , 2005, Cell Death and Differentiation.

[58]  V. Rastogi,et al.  Taming Glutamate Excitotoxicity: Strategic Pathway Modulation for Neuroprotection , 2015, CNS Drugs.

[59]  W. Danysz,et al.  The role of excitotoxicity in neurodegeneration. , 2006, Folia neuropathologica.

[60]  Siqi Liu,et al.  Necrosis, and then stress induced necrosis-like cell death, but not apoptosis, should be the preferred cell death mode for chemotherapy: clearance of a few misconceptions , 2014, Oncoscience.

[61]  A. Constantinou,et al.  Caspase-independent pathways of programmed cell death: the unraveling of new targets of cancer therapy? , 2009, Current cancer drug targets.

[62]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[63]  T. Cotter,et al.  Apoptosis and cancer: the genesis of a research field , 2009, Nature Reviews Cancer.

[64]  G. Brown,et al.  Phagoptosis - Cell Death By Phagocytosis - Plays Central Roles in Physiology, Host Defense and Pathology. , 2015, Current molecular medicine.

[65]  N. Mulet-Margalef,et al.  The Importance of Being Dead: Cell Death Mechanisms Assessment in Anti-Sarcoma Therapy , 2015, Front. Oncol..

[66]  L. Zitvogel,et al.  Pyroptosis – a cell death modality of its kind? , 2010, European journal of immunology.

[67]  Xiaomin Lou,et al.  Just like the rest of evolution in Mother Nature, the evolution of cancers may be driven by natural selection, and not by haphazard mutations , 2014, Oncoscience.

[68]  A. Columbano,et al.  Liver regeneration versus direct hyperplasia , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[69]  Sarah M. Regan,et al.  Comparison of mitotic cell death by chromosome fragmentation to premature chromosome condensation , 2010, Molecular Cytogenetics.

[70]  E. Benarroch.  Acquired axonal degeneration and regeneration , 2015, Neurology.

[71]  M. Lisanti,et al.  Reviewing once more the c-myc and Ras collaboration , 2011, Cell cycle.

[72]  R A Knight,et al.  Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012 , 2011, Cell Death and Differentiation.

[73]  Jean H. Overmeyer,et al.  Non-apoptotic cell death associated with perturbations of macropinocytosis , 2015, Front. Physiol..

[74]  D. Grignon,et al.  Histological complexities of pancreatic lesions from transgenic mouse models are consistent with biological and morphological heterogeneity of human pancreatic cancer. , 2007, Histology and histopathology.

[75]  R. Lockshin,et al.  Programmed cell death and apoptosis--where it came from and where it is going: from Elie Metchnikoff to the control of caspases. , 2012, Experimental oncology.

[76]  S. M. Fayaz,et al.  Necroptosis: who knew there were so many interesting ways to die? , 2014, CNS & neurological disorders drug targets.